# Case report: Successful treatment of a thallium sulfate intoxication in a dog with use of Prussian blue

**Authors:** Fergal M. McDermott, Anne A. Kan, Claudine C. Hunault, Joris H. Robben, Dylan W. de Lange, Marieke A. Dijkman

PMC · DOI: 10.3389/fvets.2025.1528327 · Frontiers in Veterinary Science · 2025-02-05

## TL;DR

A dog was successfully treated for thallium poisoning using Prussian blue, highlighting its effectiveness in veterinary care.

## Contribution

This is a rare case report demonstrating the successful use of Prussian blue in treating thallium intoxication in a dog.

## Key findings

- The dog showed full recovery after 11 weeks of treatment with Prussian blue and supportive care.
- Serum thallium concentrations decreased significantly during Prussian blue treatment.
- The elimination half-life of thallium during treatment was calculated to be 2.8 days.

## Abstract

Soluble thallium salts are highly toxic, with mortality rates exceeding 70% in animals compared to 6%−15% in humans. Early identification of thallium intoxicated patients and decreasing the toxic load by targeted treatment using Prussian Blue are associated with a better outcome in humans. Prussian blue, however, is rarely available or used in veterinary settings. Here we present a rare report of the successful use of Prussian Blue in the management of a dog with a thallium intoxication. A 5-year-old miniature Schnauzer, ingested a thallium sulfate based rodenticide leading to lethargy, anorexia, regurgitation, abdominal pain, borborygmi, constipation, ataxia, dermatitis and progressive alopecia. Intervention involved supportive care with subcutaneous fluids, carprofen, butylscopolamine and dexamethasone in combination with targeted treatment using the chelating agent Prussian blue (15 days) followed by activated charcoal (4 days). The serum thallium concentration on the 5th day of the Prussian Blue treatment was 196 mcg/L confirming thallium intoxication. The serum thallium concentrations were 20.7 mcg/L and 21.5 mcg/L on days 14 and 34 of treatment, respectively. The calculated elimination half-life during the during PB treatment was 2.8 days. The patient showed gradual improvement over several weeks, achieving full recovery at 11 weeks. This case emphasizes the importance of a timely diagnosis and the early start of targeted therapy using Prussian blue, in the management of thallium intoxication in veterinary patients.

## Linked entities

- **Chemicals:** thallium sulfate (PubChem CID 24833), Prussian blue (PubChem CID 2724251), butylscopolamine (PubChem CID 160883), dexamethasone (PubChem CID 5743), activated charcoal (PubChem CID 5462310)
- **Species:** Canis lupus familiaris (taxon 9615)

## Full-text entities

- **Diseases:** ataxia (MESH:D001259), constipation (MESH:D003248), dermatitis (MESH:D003872), alopecia (MESH:D000505), abdominal pain (MESH:D015746), regurgitation (MESH:D008944), lethargy (MESH:D053609), anorexia (MESH:D000855)
- **Chemicals:** activated charcoal (MESH:D002606), PB (MESH:D007854), butylscopolamine (MESH:D002086), dexamethasone (MESH:D003907), carprofen (MESH:C007005), thallium sulfate (MESH:C013707), thallium (MESH:D013793), thallium salts (MESH:C000615114), Prussian Blue (MESH:C000170)
- **Species:** Homo sapiens (human, species) [taxon 9606], Canis lupus familiaris (dog, subspecies) [taxon 9615]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC11835880/full.md

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC11835880/full.md

## References

23 references — full list in the complete paper: https://tomesphere.com/paper/PMC11835880/full.md

---
Source: https://tomesphere.com/paper/PMC11835880